Grants per year
Search results
-
Active
TEAM Registry
Cuttica, M. J. (PD/PI)
International CTEPH Association
10/1/23 → 9/30/26
Project: Research project
-
Prot #INS1009-203: An Open-Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term use of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension
Cuttica, M. J. (PD/PI)
PPD Development, Insmed Incorporated
4/24/23 → 4/24/26
Project: Research project
-
Prot #CS1-003: A Phase 2, Prospective, Randomized, Open-label, Blinded Endpoint, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of 3 Doses of CS1 in Subjects with Pulmonary Arterial Hypertension
Cuttica, M. J. (PD/PI)
Worldwide Clinical Trials, Inc., Cereno Scientific AB
12/7/22 → 12/7/25
Project: Research project
-
Classification and Prognostication in Pulmonary Thromboembolism Using Computed Tomography Image Analytics
Cuttica, M. J. (PD/PI), Cuttica, M. J. (PD/PI), Mylvaganam, R. J. (Co-Investigator) & Mylvaganam, R. J. (Co-Investigator)
Brigham and Women’s Hospital, National Heart, Lung, and Blood Institute
9/1/22 → 6/30/27
Project: Research project
-
Prot #INS1009-202: A Phase 2b, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension
Cuttica, M. J. (PD/PI)
PPD Development, Insmed Incorporated
4/1/22 → 4/1/25
Project: Research project
-
Prot #67896062PAH4005: An International, Non-drug Interventional, Real-world Cohort of PAH Patients Newly Initiating PAH Therapy with Guideline Directed Assessments of Disease Severity: CARE PAH (Contemporary Real-World PAH Best Practice)
Cuttica, M. J. (PD/PI)
Parexel, Actelion Pharmaceuticals Ltd.
1/14/22 → 4/30/27
Project: Research project
-
Prot #67896062CTP3001: Macitentan in Inoperable or Persistent/Recurrent Chronic ThromboEmbolic Pulmonary Hypertension (MACiTEPH): A Prospective, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel Group, Adaptive Phase 3 Study with Open-l
Cuttica, M. J. (PD/PI)
Janssen Research & Development, LLC
9/21/21 → 9/18/26
Project: Research project
-
Prot #21427/BAY0903201: RiOciguAt UseRs Registry - The ROAR Registry
Cuttica, M. J. (PD/PI)
Xcenda LLC, Bayer HealthCare Pharmaceuticals, Inc.
7/13/21 → 7/31/25
Project: Research project
-
Transitions from Impaired Respiratory Health to Lung Disease
Kalhan, R. (PD/PI), Kalhan, R. (PD/PI), Kalhan, R. (PD/PI), Abdala-Valencia, H. (Co-Investigator), Abdala-Valencia, H. (Co-Investigator), Cuttica, M. J. (Co-Investigator), Cuttica, M. J. (Co-Investigator), Cuttica, M. J. (Co-Investigator), Liu, K. (Co-Investigator), Liu, K. (Co-Investigator), Liu, K. (Co-Investigator), Lloyd-Jones, D. M. (Co-Investigator), Lloyd-Jones, D. M. (Co-Investigator), Lloyd-Jones, D. M. (Co-Investigator), Misharin, A. (Co-Investigator), Misharin, A. (Co-Investigator), Sala, M. A. (Co-Investigator), Sala, M. A. (Co-Investigator) & Sala, M. A. (Co-Investigator)
National Heart, Lung, and Blood Institute
1/1/20 → 6/30/25
Project: Research project